1. Germany Stocks

  2. •

    Healthcare

  3. •

    Medical - Care Facilities
Rhoen-Klinikum AG

Rhoen-Klinikum AG

RHKJF
Rhoen-Klinikum AGUS flagOther OTC
15.30
USD
- -
- -
1.02BMarket Cap

Total Valuation

Rhoen-Klinikum AG carries a market capitalization of 1.02B, placing it among publicly traded companies globally. Its enterprise value stands at 360.40M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.02B
Enterprise Value360.40M

Share Statistics

Rhoen-Klinikum AG currently has 66.94M shares outstanding.

Shares Outstanding66.94M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Rhoen-Klinikum AG trades at a trailing price-to-earnings ratio of 22.65. The price-to-sales ratio is 0.53, and the price-to-book ratio stands at 5.42.

PE Ratio22.65
PS Ratio0.53
PB Ratio5.42
P/TBV Ratio0.76
P/FCF RatioN/A
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Rhoen-Klinikum AG trades at an EV/EBITDA multiple of 9.65 and an EV/FCF ratio of 145.57. The EV/Sales ratio of 0.21 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 9.65 provides insight into valuation relative to core operating earnings.

EV / Sales0.21
EV / EBITDA9.65
EV / EBIT9.65
EV / FCF145.57

Financial Position

Rhoen-Klinikum AG maintains a current ratio of 2.57, meaning it holds 2.6x the short-term assets needed to cover near-term liabilities.

Current Ratio2.57
Quick Ratio1.63
Debt / EquityN/A
Debt / EBITDAN/A
Interest Coverage12.20

Financial Efficiency

Rhoen-Klinikum AG posts a return on equity of 23.93 and a return on invested capital of 2.22.

Return on Equity (ROE)23.93
Return on Assets (ROA)2.16
Return on Invested Capital (ROIC)2.22
Return on Capital Employed (ROCE)20.43
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover32.24

Taxes

Over the trailing twelve months, Rhoen-Klinikum AG has paid 9.95M in income taxes, reflecting an effective tax rate of 19.12.

Income Tax9.95M
Effective Tax Rate19.12

Stock Price Statistics

Rhoen-Klinikum AG's stock has gained approximately 0% over the past 52 weeks. The 50-day moving average sits at 15.30, while the 200-day moving average is 15.30.

Beta (5Y)N/A
52-Week Price Change0%
50-Day Moving Average15.30
200-Day Moving Average15.30
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Rhoen-Klinikum AG generated 1.73B in revenue and converted that into 40.05M in net income, yielding earnings per share of 0.61. EBITDA reached 37.33M, while operating income came in at 37.33M.

Revenue1.73B
Gross Profit487.15M
Operating Income37.33M
Pretax Income52.03M
Net Income40.05M
EBITDA37.33M
EBIT37.33M
Earnings Per Share (EPS)0.61

Balance Sheet

Total book value stands at 167.41M, with working capital of 559.57M providing operational flexibility.

Cash & Cash Equivalents578.26M
Total DebtN/A
Net Debt-160.44M
Equity (Book Value)167.41M
Book Value Per Share2.44
Working Capital559.57M

Margins

Rhoen-Klinikum AG operates with a gross margin of 28.22, reflecting its pricing power and cost economics. The operating margin of 2.16 and net profit margin of 2.32 provide insight into operational efficiency.

Gross Margin28.22
Operating Margin2.16
Pretax Margin3.01
Profit Margin2.32
EBITDA Margin2.16

Stock Splits

Rhoen-Klinikum AG's most recent stock split took place on July 24, 2009 with a 1000:1033 split ratio.

Last Split Date7/24/2009
Split Ratio1000:1033

Scores

Rhoen-Klinikum AG posts an Altman Z-Score of 2.66, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.66